Methyl 2,6-dichloro-5-methoxypyrimidine-4-carboxylate, 95.0%, 250mg

(2R,3S)-1-(tert-Butoxycarbonyl)-3-phenylpyrrolidine-2-carboxylic acid, 98%, 5g

2-METHYL-2-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOL-1-YL)PROPANENITRILE, 95.0%, 5g

2-(2-Amino-5-bromobenzoyl)pyridine, 95.0%, 10g

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine, 95.0%, 25g

Wide mouth bottle, 500 ml, Non-sterile, 140 Piece(s)

(1-Methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid, 95.0%, 250mg

3-Phenyl-1H-indole, 97.0%, 1g

Crystallization dishes ROTILABO® with spout, 900 ml, 140 mm, 10 Piece(s)

3-CYANO-4-NITROBENZALDEHYDE, 95.0%, 250mg

[6-Chloro-5-(trifluoromethyl)pyridin-3-yl]boronic acid, 97%, 1g

4-Acetamidobenzyl alcohol, 95.0%, 1g

AC-LEU-NH2, 97.0%, 1g